These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36196141)

  • 1. Serum proteins and electrophoretic profile in horses undergoing crotalid venom hyperimmunization.
    Ramos MGDSN; Campos SDE; Strauch MA; Ott LC; Macieira DB; de Alencar NX; Lessa DAB
    J Equine Sci; 2022 Sep; 33(3):31-35. PubMed ID: 36196141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment.
    Waghmare AB; Salvi NC; Deopurkar RL; Shenoy PA; Sonpetkar JM
    Toxicon; 2014 May; 82():83-92. PubMed ID: 24582735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: implications for the production of polyspecific snake antivenoms.
    Dos-Santos MC; Arroyo C; Solano S; Herrera M; Villalta M; Segura A; Estrada R; Gutiérrez JM; León G
    Toxicon; 2011 Feb; 57(2):237-43. PubMed ID: 21130107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
    Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
    Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.
    Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D
    J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological profile of medically relevant Crotalus species from Mexico and their neutralization by a Crotalus basiliscus/Bothrops asper antivenom.
    Sánchez M; Solano G; Vargas M; Reta-Mares F; Neri-Castro É; Alagón A; Sánchez A; Villalta M; León G; Segura Á
    Toxicon; 2020 May; 179():92-100. PubMed ID: 32345455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraspecific variability of the Central American rattlesnake (Crotalus simus) venom and its usefulness to obtain a representative standard venom.
    Gómez A; Solano G; Chang-Castillo A; Chacón D; Corrales G; Segura Á; Estrada R; León G
    Toxicon; 2021 Oct; 202():20-26. PubMed ID: 34562491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New nanostructured silica adjuvant (SBA-15) employed to produce antivenom in young sheep using Crotalus durissus terrificus and Apis mellifera venoms detoxified by cobalt-60.
    Seabra Ferreira Junior R; Pavan Anderlini R; Augusto Brazil Esteves Sant' Anna O; Carvalho Pimenta D; De Oliveira Orsi R; Barraviera B
    J Toxicol Environ Health A; 2010; 73(13-14):926-33. PubMed ID: 20563926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Quest for a Universal Plasma-Derived Antivenom Against All Elapid Neurotoxic Snake Venoms.
    Ratanabanangkoon K
    Front Immunol; 2021; 12():668328. PubMed ID: 33968072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbant assay (ELISA) of size-selected crotalid venom antigens by Wyeth's polyvalent antivenom.
    Schaeffer RC; Randall H; Resk J; Carlson RW
    Toxicon; 1988; 26(1):67-76. PubMed ID: 3347932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global proteomic and functional analysis of Crotalus durissus collilineatus individual venom variation and its impact on envenoming.
    Oliveira IS; Cardoso IA; Bordon KCF; Carone SEI; Boldrini-França J; Pucca MB; Zoccal KF; Faccioli LH; Sampaio SV; Rosa JC; Arantes EC
    J Proteomics; 2019 Jan; 191():153-165. PubMed ID: 29462664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein concentrations from clinically healthy horses determined by agarose gel electrophoresis.
    Riond B; Wenger-Riggenbach B; Hofmann-Lehmann R; Lutz H
    Vet Clin Pathol; 2009 Mar; 38(1):73-7. PubMed ID: 19171019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of horses with Crotalus durissus terrificus (South American rattlesnake) venom. A comparison of four different procedures.
    Freitas TV; Fortes-Dias CL; Diniz CR; Velarde DT; Freitas CF
    Braz J Med Biol Res; 1991; 24(3):281-90. PubMed ID: 1823242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the pathogenic threat of envenoming by South African shield-nosed and coral snakes (genus Aspidelaps), and revealing the likely efficacy of available antivenom.
    Whiteley G; Casewell NR; Pla D; Quesada-Bernat S; Logan RAE; Bolton FMS; Wagstaff SC; Gutiérrez JM; Calvete JJ; Harrison RA
    J Proteomics; 2019 Apr; 198():186-198. PubMed ID: 30290233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms.
    Otero R; Gutiérrez JM; Rojas G; Núñez V; Díaz A; Miranda E; Uribe AF; Silva JF; Ospina JG; Medina Y; Toro MF; García ME; León G; García M; Lizano S; De La Torre J; Márquez J; Mena Y; González N; Arenas LC; Puzón A; Blanco N; Sierra A; Espinal ME; Lozano R
    Toxicon; 1999 Jun; 37(6):895-908. PubMed ID: 10340829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross reactivity of mono- and polyvalent antivenoms with Viperidae and Crotalidae snake venoms.
    Kornalík F; Táborská E
    Toxicon; 1989; 27(10):1135-42. PubMed ID: 2815109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current research into snake antivenoms, their mechanisms of action and applications.
    Silva A; Isbister GK
    Biochem Soc Trans; 2020 Apr; 48(2):537-546. PubMed ID: 32196542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional and thromboelastometric-based micromethod for assessing crotoxin anticoagulant activity and antiserum relative potency against Crotalus durissus terrificus venom.
    Prezoto BC; Tanaka-Azevedo AM; Marcelino JR; Tashima AK; Nishiduka ES; Kapronezai J; Mota JO; Rocha MMT; Serino-Silva C; Oguiura N
    Toxicon; 2018 Jun; 148():26-32. PubMed ID: 29654870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANAVIP® interaction with western pygmy rattlesnake venom: In vitro assesment of reactivity using SE-HPLC.
    Tanner DA; Shults CA; Sanny C
    Toxicon; 2020 Dec; 188():159-163. PubMed ID: 33096151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.